Correlations Between the EGFR Mutation Status and Clinicopathological Features of Clinical Stage I Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Correlations Between the EGFR Mutation Status and Clinicopathological Features of Clinical Stage I Lung Adenocarcinoma

Published:2015-10 Issue:42 Volume:94 Page:e1784
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Isaka Tetsuya,Yokose Tomoyuki,Ito Hiroyuki,Nagata Masashi,Furumoto Hideyuki,Nishii Teppei,Katayama Kayoko,Yamada Kouzo,Nakayama Haruhiko,Masuda Munetaka

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference40 articles.

1. Screening for epidermal growth factor receptor mutations in lung cancer.;Rosell;N Engl J Med,2009

2. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.;Huang;Clin Cancer Res,2004

3. Mutations and addiction to EGFR: the Achilles heal of lung cancers Trends Mol M;Gazdar;ed,2004

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.;Lynch;N Engl J Med,2004

5. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions.;Pao;J Clin Oncol,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of postoperative recurrence-free survival in non–small cell lung cancer patients based on consensus clustering;Clinical Radiology;2024-10

2. Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with “adenocarcinoma” and “non‐small cell carcinoma favor adenocarcinoma”;Thoracic Cancer;2024-01-10

3. Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1–N2 epidermal growth factor receptor mutant lung adenocarcinoma;Translational Lung Cancer Research;2023-10

4. Genetic Associations of Visfatin Polymorphisms with EGFR Status and Clinicopathologic Characteristics in Lung Adenocarcinoma;International Journal of Environmental Research and Public Health;2022-11-17

5. Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status;BMC Cancer;2022-09-09